| Literature DB >> 28253266 |
Xiaohang Wu1, Weiyi Lai1, Haotian Lin1, Yizhi Liu1.
Abstract
PURPOSE: To discern and confirm genetic biomarkers that help identify populations at high risk for age-related cataract (ARC).Entities:
Mesh:
Substances:
Year: 2017 PMID: 28253266 PMCID: PMC5333819 DOI: 10.1371/journal.pone.0172092
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Systematic review of the genetic polymorphisms in previous association studies regarding age-related cataract.
| Gene | Full name | Role | Polymorphism | No. of related studies | Previous systemic review |
|---|---|---|---|---|---|
| glutathione S transferase | Antioxidant enzyme | GSTM1, GSTM3, GSTT1, GSTP1, GSTO1, GSTO2 | 13[ | Yes[ | |
| N-acetyltransferase type 2 | Antioxidant enzyme | NAT2*5A, NAT2*6A, NAT2*7A/B, NAT2*14A | 2[ | No | |
| Superoxide dismutase | Antioxidant enzyme | SOD1: rs17881180, rs2234694, rs17880135, rs2070424; SOD2: rs6917589, rs2842980, rs7855, rs5746151, rs5746136, rs4880, rs2758352; SOD3: rs2536512, rs1799895 | 2[ | No | |
| Catalase | Antioxidant enzyme | rs7943316 | 1[ | No | |
| Glutathione peroxidase | Antioxidant enzyme | rs1050450 | 1[ | No | |
| Xeroderma pigmentosum complementation group D | DNA repair enzyme (nucleotide excision repair pathway) | Codon 751, codon 312 (rs1799793) | 5[ | Yes[ | |
| X-ray cross-complementing group 1 | DNA repair enzyme (base excision repair pathway) | Codon 399 (rs25487) | 5[ | Yes[ | |
| Werner helicase | DNA repair enzyme (double-strand end resection pathway) | rs1346044, rs1801195, rs2230009, rs3087414, rs4733220, rs2725361, rs2725338, rs2725383, rs1863280, rs11574311 | 3[ | No | |
| AP endonuclease-1 | DNA repair enzyme (base excision repair pathway) | Codon 148, rs1760944 | 2[ | No | |
| ERCC excision repair 6, chromatin remodeling factor | DNA repair enzyme (nucleotide excision repair pathway) | rs4838519, rs4253038 | 1[ | No | |
| Bloom syndrome RecQ like helicase | DNA repair enzyme (double-strand end resection pathway) | rs1063147, rs7183308, rs17273206, rs8027126, rs7175811, rs3815003, rs6496724 | 1[ | No | |
| 8-oxoguanine glycosylase-1 | DNA repair enzyme (base excision repair pathway) | rs1052133, rs2072668, rs2304277, rs125701 | 5[ | No | |
| Methylenetetrahydrofolate reductase | Converts dietary folate is converted into 5-methyltetrahydrofolate, and controls serum homocysteine concentration | rs3737967, rs1801131, rs1801133, rs9651118 | 3[ | No | |
| Eph-receptor tyrosine kinase-type A2 | Member of the Eph subfamily of receptor tyrosine kinases | rs7543472, rs11260867, rs7548209, rs3768293, rs6603867, rs6678616, rs477558, rs3754334, rs707455 | 4[ | Yes[ | |
| Ephrin-A5 | Receptor protein-tyrosine kinases involved in a variety of biological processes | c.668C>T (rs201008479), c.102C>T (rs199980747), c.–27C>G (rs200187971) | 1[ | No | |
| Apolipoprotein E | Transporter of lipids and cholesterol | rs7412, rs429358 | 3[ | No | |
| Kinesin light chain 1 | Kinesin-mediated cargo vesicle transport | rs8702, rs7154572, rs7150141, rs12432994, rs8007903, rs2403205, rs4900590, rs3212102, rs3212079 | 4[ | No | |
| Heat shock transcription factor 4 | Regulator of the expression of several heat shock protein (HSP) genes | Copy number variation | 1[ | No | |
| Gap junction protein-alpha 8 | Connexin50, a gap junction protein in the eye lens | rs1495960, rs9437983 | 1[ | No | |
| Fat mass and obesity-associated gene | Management of energy homeostasis, nucleic acid demethylation, and the regulation of body fat masses by lipolysis | rs9939609, rs9939973, rs9940128, rs1421085, rs1121980, rs7193144, rs17817449, rs8050136, rs9926289 | 2[ | No | |
| Galactokinase | Phosphorylates galactose to form galactose-1-phosphate, help making UDP-glucose, glycolipids and glycoproteins | c.252G->A, c.315G->A, c.615C->G, IVS4+34G->A, c.884G->A, c.1076T->C, c.1119G->A, IVS7+43C->T (rs743554) | 1[ | No | |
| Major intrinsic protein of lens fiber | The most abundant junctional membrane protein in the mature lens | rs2269348, rs61759527, c.-4T>C, rs77163805, rs74641138, rs35033450, and rs36032520 | 1[ | No | |
| Interferon-gamma | Up regulate the first rate-limiting enzyme (IDO) in the tryptophan catabolism, which produces UV filters | +874(T/A) | 1[ | No | |
| Indoleamine 2, 3-dioxygenase | The first rate limiting enzyme involved in the tryptophan catabolism which results in the production of UV filters | c.422+90G -> A (rs4613984) | 1[ | No | |
| Nuclear factor, erythroid 2 like 2 | Regulator of antioxidant stress response | rs16865105, rs7557529, rs2886161, rs1806649, rs2001350, rs10183914, rs2706110, rs13035806 | 1[ | No | |
| Kelch like ECH associated protein 1 | Regulator of antioxidant stress response | rs1048290, rs11085735 and rs1048287 | 1[ | No | |
| Ubiquitin carboxyl-terminal esterase L1 | De-ubiquitinating enzyme with important functions in recycling of ubiquitin | c.53C ->A (rs5030732) | 1[ | No | |
| Ezrin | A member of the ezrin/radixin/moesin (ERM) protein family, plays a crucial role in the development of the lens as a plasma membrane—cytoskeleton linker | rs5881286, rs2242318, rs144581330 | 1[ | No | |
| 70 kDa heat shock protein | Controls cellular responses to stress and apoptosis | HSPA1A Codon 190, HSPA1B Codon 1267, HSPA1L Codon 2437 | 1[ | No | |
| Tudor domain-containing protein 7 | Component of RNA granule that control mRNA degradation, stabilization and subcellular localization | rs1462091, rs11793735, rs10981985, rs2045732, rs1462089 | 1[ | No | |
| Fatty acid-binding protein-2 | A protein expressed in enterocytes and is responsible for the absorption of long-chain fatty acids | Codon 54 (rs1799883) | 1[ | No | |
| Peroxisome proliferator-activated receptor gama2 | Ligand-activated transcription factor in the nuclear hormone receptor superfamily related to retinoid, steroid and thyroid hormone receptors | Codon 12 | 1[ | No | |
| Estrogen receptor | Estrogen receptor | ESR1: rs2234693, rs9340799; ESR2: rs4986938, rs1256031 | 1[ | No | |
| Cytochrome P450 | Biosynthesis and bioavailability of multiple chemicals | CYP17A1: rs743572; CYP19A1: rs10046; CYP1A1: rs1048943 | 1[ | No | |
| Catechol-O-methyltransferase | Major degradative pathway of the catecholamine transmitters | rs4680 | 1[ | No | |
| Presenilin 1 | Mutations of which were identified as causative of Alzheimer disease | rs165932, rs7523 | 1[ | No |
a Although these genes had ≥3 related association studies, each of their polymorphisms was reported in less than three studies. Therefore, they were not chosen for meta-analysis.
Fig 1PRISMA flow diagram.
Characteristics of the studies included in meta-analysis.
| First author | Year | Sample size (case/control) | Age | Gender | Case diagnosis | Control | Article language | Population ethnicity | HWE test (p value) | Quality score |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012 | 415, 386 | 65.77±6.49 | 52.3 | ARC (cortical, nuclear, posterior subcapsular, mixed) | Disease-free volunteers | English | Chinese | 0.3518 | 6 | |
| 2013 | 504, 244 | 60.2±5.7 | 47.1 | ARC (cortical, nuclear, posterior subcapsular, mixed) | Healthy eyes and no systemic disease | English | Chinese | 0.1328 | 8 | |
| 2014 | 150, 50 | 67.83±5.54 | 44.0 | ARC (cortical, nuclear, posterior subcapsular) | Normal ocular examination | English | Egyptian | 1.0000 | 6 | |
| 2015 | 402, 813 | 67.45±7.01 | 49.8 | ARC (subtypes not mentioned) | Without ARC and other age-related ocular diseases | English | Chinese | 0.4688 | 7 | |
| 2015 | 360, 392 | 66±6 | 54.8 | ARC (cortical, nuclear, posterior subcapsular) | Without cataract and systemic diseases | Chinese | Chinese | 0.2012 | 8 | |
| 2005 | 502, 187 | 65.8±6.9 | 27.3 | ARC (cortical, nuclear, posterior subcapsular, mixed) | Without cataract, uveitis and glaucoma | English | Caucasian | 0.1601, 0.2458 | 6 | |
| 2015 | 502, 890 | 67.1±11.1 | 47.6 | ARC (cortical, nuclear, posterior subcapsular, mixed) | Without cataract, other eye diseases and systemic diseases | English | Chinese | 0.6537, 0.2696 | 7 | |
| 2016 | 130, 627 | 65.3±6.9 | 46.6 | ARC (cortical) | Without cortical cataract | English | Caucasian | 0.8573, 0.2305 | 9 | |
a The mean age of control group.
b The percentage of males in control group.
c The quality of studies was assessed by Newcastle-Ottawa Scale (NOS), the quality score of which ranges from 0 (worst) to 9 (best).
d The first number is for rs1801131, and the second for rs1801133.
Fig 2Forest plots for the association analysis of OGG1 and MTHFR genes with age-related cataract.
(A) OGG1 rs1052133, association analysis of all cases in codominant model CG vs CC. (B) OGG1 rs1052133, association analysis of cortical cases in codominant model CG vs CC. (C) MTHFR rs1801133, association analysis of all cases in overdominant model CC+TT vs CT.
Fig 3Sensitivity analysis for the association of OGG1 and MTHFR genes with age-related cataract.
(A) OGG1 rs1052133, sensitivity analysis of all cases in codominant model CG vs CC. (B) OGG1 rs1052133, sensitivity analysis of cortical cases in codominant model CG vs CC. (C) MTHFR rs1801133, sensitivity analysis of all cases in overdominant model CC+TT vs CT.
Fig 4Funnel plot of the association of OGG1 and MTHFR genes with age-related cataract.
(A) OGG1 rs1052133, funnel plot of all cases in codominant model CG vs CC. (B) OGG1 rs1052133, funnel plot of cortical cases in codominant model CG vs CC. (C) MTHFR rs1801133, funnel plot of all cases in overdominant model CC+TT vs CT.
Meta-analysis for association of OGG1 polymorphism (rs1052133) with age-related cataract.
| Groups | N | Genetic model | Statistical method | I2 | ph
| OR(95%CI) | p |
|---|---|---|---|---|---|---|---|
| 5 | Co-dominant (GG vs CC) | Random | 76.3% | 0.002 | 0.009 | ||
| 5 | Co-dominant (CG vs CC) | Fixed | 12.1% | 0.336 | 0.000 | ||
| Chinese | 4 | Co-dominant (GG vs CC) | Random | 80.4% | 0.002 | 0.024 | |
| 4 | Co-dominant (CG vs CC) | Fixed | 33.9% | 0.209 | 0.000 | ||
| Egyptian | 1 | Co-dominant (GG vs CC) | / | / | / | 0.048 | |
| 1 | Co-dominant (CG vs CC) | / | / | / | 1.325 (0.660, 2.659) | 0.429 | |
| English | 4 | Co-dominant (GG vs CC) | Random | 54.5% | 0.086 | 0.039 | |
| 4 | Co-dominant (CG vs CC) | Fixed | 0.0% | 0.726 | 0.021 | ||
| Chinese | 1 | Co-dominant (GG vs CC) | / | / | / | 0.000 | |
| 1 | Co-dominant (CG vs CC) | / | / | / | 0.000 | ||
| Cortical | 3 | Co-dominant (GG vs CC) | Fixed | 0.0% | 0.505 | 0.000 | |
| 3 | Co-dominant (CG vs CC) | Fixed | 0.0% | 0.960 | 0.001 | ||
| Nuclear | 3 | Co-dominant (GG vs CC) | Fixed | 0.0% | 0.739 | 0.008 | |
| 3 | Co-dominant (CG vs CC) | Fixed | 0.0% | 0.886 | 0.012 | ||
| Posterior subcapsular | 3 | Co-dominant (GG vs CC) | Fixed | 0.0% | 0.660 | 0.041 | |
| 3 | Co-dominant (CG vs CC) | Fixed | 0.0% | 0.894 | 1.341 (0.939, 1.916) | 0.106 | |
a N: The number of included studies.
b Genetic model in this table was suggested by a model-free approach provided in methods. Results of other genetic models is shown in S1 Table.
c If I2<50%, the fixed-effects model was used, otherwise, the random-effects model was used.
d ph: p value of heterogeneity chi-squared test.
e p: p value of test of OR = 1.
Meta-analysis for association of MTHFR polymorphisms (rs1801131, rs1801133) with age-related cataract.
| Groups | N | Genetic model | Statistical method | I2 | ph
| OR(95%CI) | p |
|---|---|---|---|---|---|---|---|
| All | 3 | Overdominant (AA+CC vs AC) | Fixed | 4.5% | 0.351 | 1.181 (0.991, 1.408) | 0.063 |
| Cataract morphology | |||||||
| Cortical | 3 | Overdominant (AA+CC vs AC) | Fixed | 0.0% | 0.538 | 1.129 (0.900, 1.417) | 0.294 |
| Nuclear | 2 | Overdominant (AA+CC vs AC) | Random | 60.2% | 0.113 | 1.062 (0.632, 1.785) | 0.821 |
| Posterior subcapsular | 2 | Overdominant (AA+CC vs AC) | Fixed | 0.0% | 0.603 | 1.302 (0.909, 1.864) | 0.150 |
| Mixed | 2 | Overdominant (AA+CC vs AC) | Fixed | 34.8% | 0.216 | 0.008 | |
| All | 3 | Overdominant (CC+TT vs CT) | Fixed | 0.0% | 0.678 | 0.036 | |
| Cataract morphology | |||||||
| Cortical | 3 | Overdominant (CC+TT vs CT) | Fixed | 0.0% | 0.865 | 0.017 | |
| Nuclear | 2 | Overdominant (CC+TT vs CT) | Fixed | 0.0% | 0.672 | 1.086 (0.714, 1.651) | 0.699 |
| Posterior subcapsular | 2 | Overdominant (CC+TT vs CT) | Fixed | 0.0% | 0.671 | 0.819 (0.546, 1.227) | 0.332 |
| Mixed | 2 | Overdominant (CC+TT vs CT) | Fixed | 0.0% | 0.753 | 0.848 (0.587, 1.225) | 0.380 |
| 2 | 677CC/1298AC vs 677CC/1298AA | Random | 79.0% | 0.029 | 0.505 (0.227, 1.128) | 0.096 | |
| Cortical | 2 | 677CC/1298AC vs 677CC/1298AA | Fixed | 0.0% | 0.614 | 0.009 | |
| Nuclear | 2 | 677CC/1298AC vs 677CC/1298AA | Random | 73.7% | 0.051 | 0.653 (0.227, 1.873) | 0.428 |
| Posterior subcapsular | 2 | 677CC/1298AC vs 677CC/1298AA | Fixed | 0.0% | 0.432 | 0.025 | |
| Mixed | 2 | 677CC/1298AC vs 677CC/1298AA | Random | 90.8% | 0.001 | 0.355 (0.064, 1.968) | 0.236 |
a N: The number of included studies.
b Genetic model in this table was suggested by a model-free approach provided in methods. Results of other genetic models is shown in S2 Table.
c If I2<50%, the fixed-effects model was used, otherwise, the random-effects model was used.
d ph: p value of heterogeneity chi-squared test.
e p: p value of test of OR = 1.
f the wild genotype combination 677CC/1298AA is used as reference in the association analysis of combined genotype.